Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
Abstract Background The role and implementation of tau PET imaging for predicting subsequent cognitive decline in Alzheimer’s disease (AD) remains uncertain. This study was designed to evaluate the relationship between baseline [18F]GTP1 tau PET and subsequent longitudinal change across multiple cog...
Guardado en:
Autores principales: | Edmond Teng, Paul T. Manser, Sandra Sanabria Bohorquez, Kristin R. Wildsmith, Karen Pickthorn, Suzanne L. Baker, Michael Ward, Geoffrey A. Kerchner, Robby M. Weimer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/151ea849eff2427ead44ea9980aa2f28 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
por: Sherif Bayoumy, et al.
Publicado: (2021) -
To target Tau pathologies, we must embrace and reconstruct their complexities
por: Galina Limorenko, et al.
Publicado: (2021) -
Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein
por: Gaoping Lin, et al.
Publicado: (2021) -
A Computational Model of the Trans-Synaptic Spread of Pathogenic Tau in Early Alzheimer’s Disease
por: Bashir Sbaiti, et al.
Publicado: (2021) -
Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: James R. Hall, et al.
Publicado: (2021)